This Symposium is coordinated by the Stem Cell & Regenerative Medicine Center, at the University of Wisconsin-Madison and the BTC Institute. It brings together leading researchers advancing human pluripotent stem cell products to clinical applications for a range of degenerative diseases. Progress in clinical trials will be highlighted as well as major barriers for developing these revolutionary new therapies.

highlighted issues
  • Human pluripotent stem cell therapies for diabetes, ocular disease, spinal cord injury, Parkinson’s disease, and heart failure
  • Biomanufacturing of clinical grade cellular products
  • Overcoming immunological barriers for human pluripotent stem cell-based therapies
  • Defining safe and effective human pluripotent stem cell clinical products

The registration fee is $100, discounted to $50 for students and post-doctoral researchers. Please use the link in the header above to register and complete payment. If you’re already registered AND just need to pay, please use our general payment form.

poster contest
sponsorship Opportunities:
Exhibitor’s Agreement Form
exhibit regulations
sponsorship payment form
cancellation policy

Kapil Bharti, Ph.D., Investigator, Unit on Ocular Stem Cell & Translational Research, National Eye Institute, National Institutes of Health, Bethesda, MD

Dennis Clegg, Ph.D., Professor, Wilcox Family Chair in BioMedicine, Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, Santa Barbara, CA

Derek Hei, Ph.D., VP Manufacturing, Quality, and Regulatory, BlueRock Therapies, Cambridge, MA  Investigator,Unit on Ocular Stem Cell & Translational Research, National Eye Institute, National Institutes of Health, Bethesda, MD

Jane Lebkowski, Ph.D., President of R & D and Chief Scientific Officer, Asterias Biotherapeutics, Fremont, CA

Richard McFarland, M.D., Ph.D., Chief Regulatory Officer, Advanced Regenerative Manufacturing Institute, Manchester, NH

Philippe Menasché, M.D., Ph.D., Professor of Thoracic and Cardiovascular Surgery, University of Paris Descartes; Chief of the Heart Failure Surgery Unit, Hôpital Européen Georges Pompidou, Paris, France

Felicia Pagliuca, Ph.D., Scientific Co-Founder, Vice President of Cell Biology Research and Development, Semma Therapeutics, Cambridge, MA

David Russell, M.D., Ph.D., Professor of Medicine, Division of Hematology; Adjunct Professor of Biochemistry, University of Washington School of Medicine, Seattle, WA

Lorenz Studer, M.D., Director, Memorial Sloan-Kettering Center for Stem Cell Biology; Professor, Department of Neuroscience, Weill-Cornell Graduate School, New York, NY


Timothy J. Kamp, M.D., Professor, Medicine, Cell and Regenerative Biology; Co-director, Stem Cell and Regenerative Medicine Center, University of Wisconsin–Madison, Madison, WI

William L. Murphy, Ph.D., Professor, Biomedical Engineering, Orthopedics & Rehabilitation; Co-director, Stem Cell & Regenerative Medicine Center, University of Wisconsin–Madison, Madison, WI

James Thomson, Ph.D., John D. MacArthur Professor, Director, Regenerative Biology, Morgridge Institute for Research, University of Wisconsin – Madison, Madison, WI; Professor, Department of Molecular, Cellular, & Developmental Biology, University of California – Santa Barbara, Santa Barbara, CA